FDA approves Jemperli for advanced rectal cancer subtype
In
Investing.comBy Investing.com10/19/2026, 10:24:42 PM
EXECUTIVE SUMMARY
FDA approves Jemperli for advanced rectal cancer subtype....
Key Takeaways
- FDA approves Jemperli for advanced rectal cancer subtype.
Read Complete Original Article
Published originally on Investing.com
Related News
finance18 minutes ago
Dexcom EVP Michael Brown sells $145,316 in company stock
Dexcom EVP Michael Brown sells $145,316 in company stock....
finance18 minutes ago
Apple senior vice president, CFO Kevan Parekh sells $480,315 in shares
Apple senior vice president, CFO Kevan Parekh sells $480,315 in shares....
finance18 minutes ago
Apple principal accounting officer Ben Borders sells $442k in shares
Apple principal accounting officer Ben Borders sells $442k in shares....
finance18 minutes ago
Brazil’s Americanas exits bankruptcy proceedings
Brazil’s Americanas exits bankruptcy proceedings....
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!